Handelsbanken Fonder’s Tango Therapeutics TNGX Stock Holding History

Handelsbanken Fonder’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9M	Buy	+287,900	New	+$7.12M	0.03%	393

Other funds holding TNGX

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Handelsbanken Fonder's TNGX Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 287,900 shares worth $9M. The stake represents 0.03% of the portfolio and ranks #393 among its holdings.

31 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Handelsbanken Fonder held 287,900 shares of Tango Therapeutics worth $9M as of Q2 2026.
Tango Therapeutics was a new Handelsbanken Fonder position in Q2 2026.
Tango Therapeutics made up 0.03% of Handelsbanken Fonder's portfolio in Q2 2026, its #393 holding.
31 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.